Results 251 to 260 of about 123,453 (307)
Some of the next articles are maybe not open access.
The role of plasminogen activators in stroke treatment: fibrinolysis and beyond.
Lancet Neurology, 2018Although recent technical advances in thrombectomy have revolutionised acute stroke treatment, prevalence of disability and death related to stroke remain high. Therefore, plasminogen activators-eukaryotic, bacterial, or engineered forms that can promote
Audrey M Thiebaut +6 more
semanticscholar +1 more source
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2006
Reperfusion therapy for ST-elevation acute coronary syndromes aims at early and complete recanalization of the infarct-related artery to salvage myocardium and improve both early and late clinical outcomes. Prehospital diagnosis of ST-elevation acute coronary syndrome can be made by electrocardiography with or without transtelephonic transmission, and ...
openaire +2 more sources
Reperfusion therapy for ST-elevation acute coronary syndromes aims at early and complete recanalization of the infarct-related artery to salvage myocardium and improve both early and late clinical outcomes. Prehospital diagnosis of ST-elevation acute coronary syndrome can be made by electrocardiography with or without transtelephonic transmission, and ...
openaire +2 more sources
Translational research : the journal of laboratory and clinical medicine, 2019
The minimally invasive surgery plus fibrinolysis has been identified as a promising treatment for spontaneous intracerebral hemorrhage (ICH). However, the fibrinolytic efficacy is not satisfactory.
Q. Tan +9 more
semanticscholar +1 more source
The minimally invasive surgery plus fibrinolysis has been identified as a promising treatment for spontaneous intracerebral hemorrhage (ICH). However, the fibrinolytic efficacy is not satisfactory.
Q. Tan +9 more
semanticscholar +1 more source
Chest, 1992
Fibrinolytic therapy has an expanding role in the treatment of many thromboembolic disorders. Four fibrinolytic drugs are currently marketed: streptokinase, anisoylated plasminogen-streptokinase activator complex, urokinase, and recombinant human tissue-type plasminogen activator.
openaire +2 more sources
Fibrinolytic therapy has an expanding role in the treatment of many thromboembolic disorders. Four fibrinolytic drugs are currently marketed: streptokinase, anisoylated plasminogen-streptokinase activator complex, urokinase, and recombinant human tissue-type plasminogen activator.
openaire +2 more sources
Annales de l'anesthesiologie francaise, 1979
A large number of methods may be used in the study of fibrinolysis. They are either so-called direct when they demonstrate abnormal lytic activity and indirect when they analyse the results of this activity. In practical terms, the examinations used most widely are the euglobulin lysis test, evaluation of the plasminogenplasmin pair, and estimations of
G, Levy, A, Michault, M, Jamet
openaire +1 more source
A large number of methods may be used in the study of fibrinolysis. They are either so-called direct when they demonstrate abnormal lytic activity and indirect when they analyse the results of this activity. In practical terms, the examinations used most widely are the euglobulin lysis test, evaluation of the plasminogenplasmin pair, and estimations of
G, Levy, A, Michault, M, Jamet
openaire +1 more source